በዲስትሪክት ኦፍ ኮሎምቢያ ለግሊዎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለግሊዎማ የሚደረጉ 14 ጥናቶች በዲስትሪክት ኦፍ ኮሎምቢያ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በዲስትሪክት ኦፍ ኮሎምቢያ ውስጥ ያሉ ከተሞች
Official study text (English)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07326566ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 2
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06838676NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
- Children's National Hospital, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ3 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT07664176Targeted Pediatric High-Grade Glioma Therapy
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05096481Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT04485559MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
- Children's National Hospital, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ1 እስከ 26 · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁላይ 2026 · NCT06712875Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT06333899A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- Children's National Hospital, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 4 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ጁን 2026 · NCT04573140Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 2
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ29 ሜይ 2026 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Sibley Memorial Hospital, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06810544A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ18 ማርች 2026 · NCT04655404ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።